FRANKFURT, Sept 30 (Reuters) - German healthcare company Fresenius said on Tuesday it raised the credit facility to pay for the takeover of APP Pharmaceuticals by $500 million to $2.95 billion due to strong demand from investors.

The company increased a loan with a maturity of 6 years to $1.5 billion, it said. The credit facility also consists in a revolving credit facility of $450 million with a maturity of 5 years and a $1 billion loan which matures in 5 years.

Fresenius announced in July it planned to buy APP for $3.7 billion.

(Reporting by Peter Dinkloh; Editing by David Cowell) Keywords: FFRESENIUS/ tf.TFN-Europe_newsdesk@thomson.com vs COPYRIGHT Copyright Thomson Financial News Limited 2008. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior